Electromedical Technologies is a bioelectronics manufacturing and marketing company. We offer U.S. Food and Drug Administration (FDA) cleared medical devices for pain management.
Company profile
Ticker
EMED
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
IRS number
822619815
Latest filings (excl ownership)
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
8-K
Departure of Directors or Certain Officers
5 Jul 23
10-Q
2023 Q1
Quarterly report
12 May 23
8-K
Regulation FD Disclosure
20 Apr 23
10-K
2022 FY
Annual report
31 Mar 23
8-K
Entry into a Material Definitive Agreement
21 Mar 23
8-K
Material Modifications to Rights of Security Holders
1 Feb 23
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 138.48 k | 138.48 k | 138.48 k | 138.48 k | 138.48 k | 138.48 k |
Cash burn (monthly) | 92.59 k | 26.70 k | 79.68 k | 174.94 k | 92.59 k | 116.63 k |
Cash used (since last report) | 553.20 k | 159.54 k | 476.03 k | 1.05 mm | 553.20 k | 696.81 k |
Cash remaining | -414.73 k | -21.06 k | -337.56 k | -906.73 k | -414.73 k | -558.33 k |
Runway (months of cash) | -4.5 | -0.8 | -4.2 | -5.2 | -4.5 | -4.8 |
Institutional ownership, Q2 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Feb 23 | III R. Leslie Hymers | Common Stock | Grant | Acquire A | No | No | 0.0085 | 35,000,000 | 297.50 k | 35,049,295 |
2 Nov 22 | Lee Benson | Common Stock | Grant | Acquire A | Yes | No | 0 | 1,658,999 | 0.00 | 1,658,999 |